Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.
Press releases published on May 23, 2025

R3 Stem Cell Publishes Podcast Called Stem Cell Genius to Educate Consumers on Regenerative Medicine
The world's largest provider of regenerative therapies, R3 Stem Cell, has launched a new podcast called Stem Cell Genius. SCOTTSDALE, AZ, UNITED STATES, May 23, 2025 /EINPresswire.com/ -- The world's largest provider of regenerative therapies, R3 Stem …

Global IVF Services Market: Key Trends, Market Share, Growth Drivers, And Forecast For 2025-2034
The Business Research Company's IVF Services Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 23, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores …

Top Growth Driver In The Psoriasis Market 2025: Growing Geriatric Population Boosting Market
The Business Research Company's Psoriasis Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 23, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores …

Eyewear Global Market Report 2025: Strong Market Growth Predicted With Trends and Drivers
The Business Research Company’s Hand Eyewear Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 23, 2025 /EINPresswire.com/ -- What is the Current Size of the Eyewear Market and How will …

BioSig Technologies, Inc. Signs Definitive Share Exchange Agreement with Streamex Exchange Corp. to Launch First-Mover Real-World Asset (RWA) Tokenization Company Bringing Commodity Markets On-Chain.
Los Angeles, CA and Vancouver, BC, May 23, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company, today announced it has signed a definitive share exchange agreement with Streamex …

Key Market Driver In Veterinary Biomarkers Industry 2025: The Increasing Pet Ownership Propelling The Growth Of Market
The Business Research Company's Veterinary Biomarkers Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 23, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report …

Electrocardiography ECG Electrodes Market Analysis: Key Trends, Share, Growth Drivers, And Forecast 2025-2034
The Business Research Company's Electrocardiography ECG Electrodes Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 23, 2025 /EINPresswire.com/ -- The electrocardiography ECG …

IMUNON Announces Up To $9.75 Million Private Placement Priced At-The-Market Under Nasdaq Rules
$3.25 million upfront with up to an additional $6.5 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants LAWRENCEVILLE, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company …

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, May 23, 2025 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”) announced today that its shareholders voted in …

Information on the total number of voting rights and shares
Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), May 23, 2025, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext …

Informations sur le nombre total de droits de vote et d'actions
Informations sur le nombre total de droits de vote et d'actions Mont-Saint-Guibert (Belgique), le 23 mai 2025, 22:30h CET / 16:30h ET – Conformément à l'article 15 de la loi du 2 mai 2007 relative à la publicité des participations importantes, Nyxoah SA ( …

Barentz strengthens its pharmaceuticals market presence in APAC through the envisaged acquisition of Fengli in China
SINGAPORE, May 23, 2025 /EINPresswire.com/ -- Barentz, a leading global specialty ingredients solutions provider, has entered into exclusive discussions to acquire 100% equity of Fengli Group, one of the market-leading specialty chemicals distributors …

Polyrizon Announces Receipt of Nasdaq Delisting Notice
Raanana, Israel, May 23, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced that it has received a …

Plus Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
HOUSTON, May 23, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”) today announced it received a delinquency notification letter from Nasdaq on May 21, 2025, which indicated that the Company was not in compliance with Nasdaq …

Dr. Tarang krishna & Dr. Deepika Krishna Join Sri Sri Hospital to Launch Cancer Healer & Integrative Center in Bengaluru
MUMBAI, MAHARASHTRA , INDIA, May 23, 2025 /EINPresswire.com/ -- Dr. Tarang Krishna and Dr. Deepika Krishna Join Hands with Sri Sri Ayurvedic Hospital of Gurudev Sri Sri Ravi Shankar Ji to Launch a Pioneering Cancer Healer Center …

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
IRVINE, Calif., May 23, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications, …

PMV Pharmaceuticals to Participate at Upcoming Investor Conferences
PRINCETON, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that …

Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F
Jilin, China, May 23, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, …

Boundless Bio Announces Portfolio Prioritization and Runway Extension
Portfolio prioritization focuses on novel-novel combination therapy of BBI-355 and BBI-825 and new development candidate, BBI-940, for novel kinesin program Operating runway extended into the first half of 2028, through expected proof-of-concept clinical …

Tevogen Bio Plans to Expand Specialty Care Pipeline to Include Patients 65+, Building on Previous Forecast of Nearly $1 Billion in Launch-Year; Updated rNPV to Follow
WARREN, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced a planned expansion of TVGN 489’s target population to include patients 65 and older. As previously reported in October 2024, …